Skip to main content
Livermore
Livermore
ZHEN

Intellia Therapeutics, Inc.

NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001652130

In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.

Superinvestors holding NTLA, Q2 2026

1 superinvestor reports holding Intellia Therapeutics, Inc. on Form 13F, worth $285.5M in total. Weight is Intellia Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding NTLA in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
ARK InvestCathie Wood1.9%16,875,684$285.5MAdded+16.3%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of NTLA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+16.3%)

  2. Q1 2026

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+2.1%)

  3. Q4 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+19.2%)

  4. Q3 2025

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−8.4%)

  5. Q2 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+0.1%)

  6. Q1 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+3.8%)

  7. Q4 2024

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+2.3%)

  8. Q3 2024

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+5.7%)

  9. Q2 2024

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+5.5%)

  10. Q1 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−3.7%)

  11. Q4 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+14.7%)

  12. Q3 2023

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+4.4%)

  13. Q2 2023

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−3.2%)
    Sold out
    Viking Global Investors

  14. Q1 2023

    2 superinvestors holding at quarter end

    Added
    ARK Invest (+4.4%)
    Reduced
    Viking Global Investors (−22.4%)

  15. Q4 2022

    2 superinvestors holding at quarter end

    Added
    Viking Global Investors (+7.0%)
    Reduced
    ARK Invest (−2.4%)

  16. Q3 2022

    2 superinvestors holding at quarter end

    Added
    ARK Invest (+1.5%)
    Reduced
    Viking Global Investors (−15.2%)

  17. Q2 2022

    2 superinvestors holding at quarter end

    Added
    ARK Invest (+5.9%)
    Reduced
    Viking Global Investors (−9.7%)

  18. Q1 2022

    2 superinvestors holding at quarter end

    Added
    ARK Invest (+13.4%), Viking Global Investors (+56.3%)
    Sold out
    Coatue Management

  19. Q4 2021

    3 superinvestors holding at quarter end

    Added
    ARK Invest (+17.4%), Viking Global Investors (+23.4%)
    Reduced
    Coatue Management (−51.1%)

  20. Q3 2021

    3 superinvestors holding at quarter end

    New
    Coatue Management
    Added
    Viking Global Investors (+31.2%)
    Reduced
    ARK Invest (−12.2%)

  21. Q2 2021

    2 superinvestors holding at quarter end

    New
    Viking Global Investors
    Reduced
    ARK Invest (−20.1%)